|
|
 |
|
ELN: Elan Corp Plc - Stock News |
Enter Ticker:
|
|
| Nov 13, 2009 |
Elan to Present at Lazard Capital Markets Annual Healthcare Conference07000000 |
| Nov 11, 2009 |
BiomedReports: News and FDA Updates for Alexion (Nasdaq:ALXN), Biogen (NASDAQ:BIIB), Elan (NYSE:ELN) |
| Nov 10, 2009 |
Elan to Present at Lazard Capital Markets 6th Annual Healthcare Conference |
| Nov 10, 2009 |
Elan Corp (ELN) NewsBite - ELN Could Be On the Move |
| Nov 06, 2009 |
Elan Down 5.7% Since SmarTrend's Sell Recommendation |
| Oct 29, 2009 |
Elan Corporation Plc Announces Expiration of Tender Offer for 73/4% Senior Fixed Rate Notes Due 2011 |
| Oct 29, 2009 |
Elan Corp (ELN) NewsBite - ELN Downgraded By UBS |
| Oct 29, 2009 |
Elan Corp. plc (ELN) Downgrade Alert, Watch for 23.1% Technical Downtrend Continuation |
| Oct 29, 2009 |
CORRECTION: Analyst Downgrades for October 29th |
| Oct 29, 2009 |
Analyst Downgrades for October 29th |
| Oct 28, 2009 |
Elan Posts 3Q 2009 Financial Results |
| Oct 27, 2009 |
Subset Data from Two Randomized Phase 3 Trials Show TYSABRI Significantly Reduces Rates of Hospitalization in Patients with Moderate-to-Severe Crohn's Disease |
| Oct 26, 2009 |
BUYINS.NET: Elan Corp (ELN) Daily Short Sale Trading Volume Through 10-23-09 |
| Oct 23, 2009 |
Elan Down 12.8% Since SmarTrend's Sell Recommendation |
| Oct 23, 2009 |
Fundamental Analysis on ELN, GME, LPL, ETN, MET and LUK brought toyou by AnalystChoice.com |
| |
| ZACKS COMMENTARY FOR ELN |
| Nov 18, 2009 | Zacks Equity Research: Report for ELN | | Oct 28, 2009 | Zacks Blog: FDA Approval for Glaxo Drug | | Oct 21, 2009 | Zacks Blog: Zacks Analyst Blog Highlights: Biogen Idec, Elan, UnitedHealth Group Inc., Forest Laboratories, Inc. and Cypress Biosciences | | Oct 20, 2009 | Zacks Blog: Biogen Reports Higher Earnings | | Oct 14, 2009 | Zacks Blog: Zacks Bull and Bear of the Day Highlights: VimpelCom, Rite Aid Corporation, Johnson & Johnson, Elan Pharmaceuticals and Gilead Sciences, Inc. | | Oct 14, 2009 | Zacks Blog: Zacks Analyst Blog Highlights: American International Group, Morgan Stanley, Elan Corporation, Biogen Idec and Johnson & Johnson | | Oct 13, 2009 | Zacks Blog: Subpoena for Elan | | Oct 13, 2009 | Zacks Blog: J&J Beats & Raises Guidance | | Sep 29, 2009 | Zacks Blog: J&J Joins Vaccine Bandwagon | | Sep 28, 2009 | Zacks Blog: Deal Modification for Elan, J&J | | Sep 15, 2009 | Zacks Blog: Elan, J&J Redesign Deal | | Sep 14, 2009 | Zacks Blog: Company News for September 14, 2009 |
|
|